Literature DB >> 33435953

LncRNA SNHG16 contributes to tumor progression via the miR-302b-3p/SLC2A4 axis in pancreatic adenocarcinoma.

Hao Xu1,2,3, Xin Miao4, Xin Li1,2,3, Haofei Chen1,2,3, Bo Zhang1,2,3, Wence Zhou5,6,7.   

Abstract

BACKGROUND: It has been reported that the lncRNA SNHG16 has significantly increased expression in pancreatic adenocarcinoma (PC). However, the functions and mechanisms of SNHG16 are not clear. The aim of this study was to explore the effects of SNHG16 on PC.
METHODS: qRT-PCR analysis was applied to detect the expression levels of SNHG16, miR-302b-3p and SLC2A4 in PC tissues and cells. CCK8 and EdU assays were used to evaluate the proliferation of PC cells. Transwell assays were used to assess PC cell migration and invasion. Apoptosis was evaluated by flow cytometry, and the expression of apoptosis-related proteins (including Bax, Bcl-2, cleaved caspase-3 and cleaved caspase-9) was tested by western blotting. The interactions between miR-302b-3p and SNHG16 or miR-302b-3p and the 3'UTR of SLC2A4 mRNA were clarified by a dual luciferase reporter assay and RNA immunoprecipitation.
RESULTS: SNHG16 expression was significantly elevated in PC tissues and cell lines and was associated with poor prognosis of PC patients. Knockdown of SNHG16 reduced PC cell proliferation, migration and invasion. SNHG16 acted as a sponge to regulate miR-302b-3p expression in PC cells. In addition, miR-302b-3p targeted SLC2A4 directly.
CONCLUSIONS: SNHG16 promoted the progression of PC via the miR-302b-3p/SLC2A4 axis and was expected to be a potential target for the early diagnosis and treatment of PC.

Entities:  

Keywords:  Pancreatic adenocarcinoma; SLC2A4; SNHG16; miR-302b-3p

Year:  2021        PMID: 33435953      PMCID: PMC7805184          DOI: 10.1186/s12935-020-01715-9

Source DB:  PubMed          Journal:  Cancer Cell Int        ISSN: 1475-2867            Impact factor:   5.722


  21 in total

1.  lncRNA SNHG16 promotes glioma tumorigenicity through miR-373/EGFR axis by activating PI3K/AKT pathway.

Authors:  Xiang-Yang Zhou; Hong Liu; Zheng-Bin Ding; Hai-Peng Xi; Guang-Wei Wang
Journal:  Genomics       Date:  2019-06-19       Impact factor: 5.736

Review 2.  Long noncoding RNA SNHG16 targets miR-146a-5p/CCL5 to regulate LPS-induced WI-38 cell apoptosis and inflammation in acute pneumonia.

Authors:  Zhiming Zhou; Yuyin Zhu; Guosheng Gao; Yena Zhang
Journal:  Life Sci       Date:  2019-05-07       Impact factor: 5.037

3.  Analysis of prostatic acid phosphatase in urine voided before and after massage of the prostate in infertile men.

Authors:  P J Moberg; J Lizana; P Eneroth
Journal:  Urol Int       Date:  1984       Impact factor: 2.089

Review 4.  Long noncoding RNA in prostate, bladder, and kidney cancer.

Authors:  Elena S Martens-Uzunova; René Böttcher; Carlo M Croce; Guido Jenster; Tapio Visakorpi; George A Calin
Journal:  Eur Urol       Date:  2013-12-14       Impact factor: 20.096

5.  LncRNA HOTTIP modulates cancer stem cell properties in human pancreatic cancer by regulating HOXA9.

Authors:  Zhiqiang Fu; Changhao Chen; Quanbo Zhou; Yinxue Wang; Yue Zhao; Xiaohui Zhao; Wenzhu Li; Shangyou Zheng; Huilin Ye; Lin Wang; Zhanghai He; Qing Lin; Zhihua Li; Rufu Chen
Journal:  Cancer Lett       Date:  2017-09-22       Impact factor: 9.756

6.  The endogenous retrovirus-derived long noncoding RNA TROJAN promotes triple-negative breast cancer progression via ZMYND8 degradation.

Authors:  Xi Jin; Xiao-En Xu; Yi-Zhou Jiang; Yi-Rong Liu; Wei Sun; Ya-Jie Guo; Yi-Xing Ren; Wen-Jia Zuo; Xin Hu; Sheng-Lin Huang; Hong-Jie Shen; Fei Lan; Yun-Fei He; Guo-Hong Hu; Gen-Hong Di; Xiang-Huo He; Da-Qiang Li; Suling Liu; Ke-Da Yu; Zhi-Ming Shao
Journal:  Sci Adv       Date:  2019-03-06       Impact factor: 14.136

7.  Long noncoding RNA MALAT1 releases epigenetic silencing of HIV-1 replication by displacing the polycomb repressive complex 2 from binding to the LTR promoter.

Authors:  Di Qu; Wei-Wei Sun; Li Li; Li Ma; Li Sun; Xia Jin; Taisheng Li; Wei Hou; Jian-Hua Wang
Journal:  Nucleic Acids Res       Date:  2019-04-08       Impact factor: 16.971

8.  RREB1-induced upregulation of the lncRNA AGAP2-AS1 regulates the proliferation and migration of pancreatic cancer partly through suppressing ANKRD1 and ANGPTL4.

Authors:  Bingqing Hui; Hao Ji; Yetao Xu; Juan Wang; Zhonghua Ma; Chongguo Zhang; Keming Wang; Yan Zhou
Journal:  Cell Death Dis       Date:  2019-02-27       Impact factor: 8.469

9.  Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium.

Authors:  Michael Goggins; Kasper Alexander Overbeek; Randall Brand; Sapna Syngal; Marco Del Chiaro; Detlef K Bartsch; Claudio Bassi; Alfredo Carrato; James Farrell; Elliot K Fishman; Paul Fockens; Thomas M Gress; Jeanin E van Hooft; R H Hruban; Fay Kastrinos; Allison Klein; Anne Marie Lennon; Aimee Lucas; Walter Park; Anil Rustgi; Diane Simeone; Elena Stoffel; Hans F A Vasen; Djuna L Cahen; Marcia Irene Canto; Marco Bruno
Journal:  Gut       Date:  2019-10-31       Impact factor: 23.059

10.  BBCancer: an expression atlas of blood-based biomarkers in the early diagnosis of cancers.

Authors:  Zhixiang Zuo; Huanjing Hu; Qingxian Xu; Xiaotong Luo; Di Peng; Kaiyu Zhu; Qi Zhao; Yubin Xie; Jian Ren
Journal:  Nucleic Acids Res       Date:  2020-01-08       Impact factor: 16.971

View more
  1 in total

Review 1.  Impact of Non-Coding RNAs on Chemotherapeutic Resistance in Oral Cancer.

Authors:  Karen Yamaguchi; Tomofumi Yamamoto; Junichiro Chikuda; Tatsuo Shirota; Yusuke Yamamoto
Journal:  Biomolecules       Date:  2022-02-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.